Placebo (matched to semaglutide) + Zenagamtide for obesity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 25 Jun 2026: Trial registered, NCT07668414
  2. 22 Sep 2026: Trial started, NCT07668414

The trials

NCT07668414: A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

State
Under way
Phase
Phase 3
People
650 planned
Started
22 Sep 2026
Primary completion
10 Oct 2028
Arms
Zenagamtide
Results
None posted
  1. 25 Jun 2026: Trial registered
  2. 22 Sep 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.